RECURSION PHARMACEUTICALS, INC. — insider transactions
1 transactions on record · RXRX · CIK 1601830
Aggregates
computed from the filings belowPurchases, 12m
0
count of open-market buys
Sales, 12m
1
count of open-market sales
Buy / sell ratio, 12m
0.00
purchases per sale
Distinct insiders, 12m
1
Bought, 3m
$0
Sold, 3m
$158.5K
Median disclosure lag
2.0 d
trade date to filing date
Largest single trade, 24m
$158.5K
2026-07-07
Director share, 12m
100.0%
of transactions where role is stated
Current run
1 sells
consecutive same-direction transactions
Net 3m flow
-$158.5K
purchases minus sales
Total on record
1
Transactions
1 most recent shown| Disclosed | Traded | Lag, d | Insider | Role | Transaction | Shares | Price | Value | Source |
|---|---|---|---|---|---|---|---|---|---|
| 2026-07-09 | 2026-07-07 | 2 | Borgeson Blake | Director | Open market sale | 40,000 | $3.96 | $158.5K | filing |